Home > Insider Trading > Filing (0000884905-17-000076)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884905	Praxair Inc	PX	Industrial Inorganic Chemicals (2810)	061249050

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1119504	W Raymond Leboeuf	C/O Praxair, Inc. 39 Old Ridgebury Road Danbury CT 06810-5113		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-07	6,550	$61.47	16,697	No	4	M	Direct
Common Stock	Disposition	2016-11-07	6,550	$117.26	10,147	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-11-07	6,550	$0.00	6,550	$61.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-02-27	2017-02-27	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$83.89	2009-02-26	2018-02-26	3,885	3,885	Direct
Common Stock	Stock Option (right to buy)	$60.92	2010-02-24	2019-02-24	4,600	4,600	Direct
Common Stock	Deferred Stock	$0.00			48,566	48,566	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-02-26	3,885	3,885	Direct
2019-02-24	4,600	4,600	Direct
	48,566	48,566	Direct

Footnotes

The $117.263 price reported is the weighted average sale price. The sale prices ranged from $117.258 to $117.288 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
Conversion to Praxair Common Stock is on a 1-for-1 basis.
Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service.